patent

Developing a new drug can cost well over a billion dollars and more than a decade, yet a finished pill is often cheap and easy to copy. A patent is the legal bargain that makes that investment survivable: in exchange for publicly disclosing an invention, the inventor receives a time-limited exclusive right to stop others from making, using, or selling it. For drugs, it is the temporary fence that lets a company recoup the enormous cost of discovery and trials.

A patent protects an invention that is novel, useful, and non-obvious. In medicinal chemistry the most valuable is the composition-of-matter patent on a new chemical entity itself — the molecule and its close relatives — but companies also patent salt forms, crystal forms, formulations, manufacturing routes, and new medical uses. The term typically runs twenty years from filing, but because much of that time is consumed by development and regulatory review, the effective commercial life under patent is often far shorter, sometimes partly restored by regulatory extensions.

When key patents expire, competitors may launch generic or biosimilar versions, prices fall sharply, and the original drug faces the so-called patent cliff. A patent grants only the right to exclude others; it does not by itself confer the right to sell, which still requires separate regulatory approval. The two systems are independent: a patented molecule may never be approved, and an approved drug may have lost its patent protection.